Matches in Nanopublications for { ?s ?p "[The aim of this study was to determine if there is any difference in PML protein expression in breast cancer of BRCA1 and BRCA2 gene mutation carriers compared to sporadic breast cancer and if the PML protein can be used as a prognostic marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- NP480643.RAR7pZzvEyvmqwWn0U2q7QZSMUAAylgZaRbGpy2G4qQ7U130_assertion description "[The aim of this study was to determine if there is any difference in PML protein expression in breast cancer of BRCA1 and BRCA2 gene mutation carriers compared to sporadic breast cancer and if the PML protein can be used as a prognostic marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480643.RAR7pZzvEyvmqwWn0U2q7QZSMUAAylgZaRbGpy2G4qQ7U130_provenance.
- NP811879.RAReR20ktX41UhnTg_iHxLWkf7GyMGX_bBlESoEDS27s4130_assertion description "[The aim of this study was to determine if there is any difference in PML protein expression in breast cancer of BRCA1 and BRCA2 gene mutation carriers compared to sporadic breast cancer and if the PML protein can be used as a prognostic marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP811879.RAReR20ktX41UhnTg_iHxLWkf7GyMGX_bBlESoEDS27s4130_provenance.
- assertion description "[The aim of this study was to determine if there is any difference in PML protein expression in breast cancer of BRCA1 and BRCA2 gene mutation carriers compared to sporadic breast cancer and if the PML protein can be used as a prognostic marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The aim of this study was to determine if there is any difference in PML protein expression in breast cancer of BRCA1 and BRCA2 gene mutation carriers compared to sporadic breast cancer and if the PML protein can be used as a prognostic marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The aim of this study was to determine if there is any difference in PML protein expression in breast cancer of BRCA1 and BRCA2 gene mutation carriers compared to sporadic breast cancer and if the PML protein can be used as a prognostic marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP628816.RADxSP53f2bGbIgJFoFKnflvapK_Qu_LLEbp-81vx7wuw130_assertion description "[The aim of this study was to determine if there is any difference in PML protein expression in breast cancer of BRCA1 and BRCA2 gene mutation carriers compared to sporadic breast cancer and if the PML protein can be used as a prognostic marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628816.RADxSP53f2bGbIgJFoFKnflvapK_Qu_LLEbp-81vx7wuw130_provenance.
- NP628813.RAV_qFwFQr173AKiO1Srj1fZ3eKhKQdBAYhShHwdDhkEs130_assertion description "[The aim of this study was to determine if there is any difference in PML protein expression in breast cancer of BRCA1 and BRCA2 gene mutation carriers compared to sporadic breast cancer and if the PML protein can be used as a prognostic marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628813.RAV_qFwFQr173AKiO1Srj1fZ3eKhKQdBAYhShHwdDhkEs130_provenance.
- NP788173.RAmtFuMSzQz-lU1gXSJZGn8hzLW12bajr3ieEUMnXjBpU130_assertion description "[The aim of this study was to determine if there is any difference in PML protein expression in breast cancer of BRCA1 and BRCA2 gene mutation carriers compared to sporadic breast cancer and if the PML protein can be used as a prognostic marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788173.RAmtFuMSzQz-lU1gXSJZGn8hzLW12bajr3ieEUMnXjBpU130_provenance.
- NP628809.RAonYfizdxH0o5RnAn6UBaEGstwew9Dyz9z1n4vOGncc0130_assertion description "[The aim of this study was to determine if there is any difference in PML protein expression in breast cancer of BRCA1 and BRCA2 gene mutation carriers compared to sporadic breast cancer and if the PML protein can be used as a prognostic marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628809.RAonYfizdxH0o5RnAn6UBaEGstwew9Dyz9z1n4vOGncc0130_provenance.
- NP628811.RALDOmI_dN0MKjREpSuyqnZ9sE27r1Z0Xn3mC39ObRTFg130_assertion description "[The aim of this study was to determine if there is any difference in PML protein expression in breast cancer of BRCA1 and BRCA2 gene mutation carriers compared to sporadic breast cancer and if the PML protein can be used as a prognostic marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628811.RALDOmI_dN0MKjREpSuyqnZ9sE27r1Z0Xn3mC39ObRTFg130_provenance.
- NP628814.RALeHRCiVaE9ZZ-c4Qf4qfO6gv0QPJEa-oD5UdlFcWJxc130_assertion description "[The aim of this study was to determine if there is any difference in PML protein expression in breast cancer of BRCA1 and BRCA2 gene mutation carriers compared to sporadic breast cancer and if the PML protein can be used as a prognostic marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628814.RALeHRCiVaE9ZZ-c4Qf4qfO6gv0QPJEa-oD5UdlFcWJxc130_provenance.
- NP628817.RAISY_bXlcw-Wo76FogBqDM6KVrKq8gxpYWwXPKVE3CFc130_assertion description "[The aim of this study was to determine if there is any difference in PML protein expression in breast cancer of BRCA1 and BRCA2 gene mutation carriers compared to sporadic breast cancer and if the PML protein can be used as a prognostic marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628817.RAISY_bXlcw-Wo76FogBqDM6KVrKq8gxpYWwXPKVE3CFc130_provenance.
- NP628818.RALzMm5E4Hkw4q-hIwxvWLH-Q4t_1LvSriK09Vrf1dNrQ130_assertion description "[The aim of this study was to determine if there is any difference in PML protein expression in breast cancer of BRCA1 and BRCA2 gene mutation carriers compared to sporadic breast cancer and if the PML protein can be used as a prognostic marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628818.RALzMm5E4Hkw4q-hIwxvWLH-Q4t_1LvSriK09Vrf1dNrQ130_provenance.
- NP788029.RAz-HIrScQgjnXN0prFOon6og8u3l85OJUWdbd7lZ9f9w130_assertion description "[The aim of this study was to determine if there is any difference in PML protein expression in breast cancer of BRCA1 and BRCA2 gene mutation carriers compared to sporadic breast cancer and if the PML protein can be used as a prognostic marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788029.RAz-HIrScQgjnXN0prFOon6og8u3l85OJUWdbd7lZ9f9w130_provenance.